Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Sample Type, By End User, By Region and Competition, 2020-2030F

Description

The Global Drug Screening Market, valued at USD 5.56 Billion in 2024, is projected to experience a CAGR of 5.3% to reach USD 7.58 Billion by 2030. The global drug screening market is defined by the development, production, and distribution of testing solutions designed to detect illicit substances, controlled medications, and their metabolites in biological samples. This market's growth is primarily driven by the escalating global incidence of substance abuse and stringent regulatory mandates for drug testing across diverse sectors, including workplaces and transportation.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 5.56 Billion
Market Size 2030	USD 7.58 Billion
CAGR 2025-2030	5.3%
Fastest Growing Segment	Urine Samples
Largest Market	North America

Key Market Drivers

The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.

Key Market Challenges

The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.

Key Market Trends

Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.

Key Market Players

Quest Diagnostics Inc.
Heska Corporation
Thermo Fisher Scientific, Inc.
Alfa Scientific Designs, Inc.
OraSure Technologies, Inc.
F. Hoffmann-La Roche Ltd
MPD Inc.
Shimadzu Corporation
Lifeloc Technologies, Inc.
Dragerwerk AG & Co. KGaA
Premier Biotech, Inc.
Omega Laboratories, Inc.

Report Scope:

In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Screening Market, By Product & Services:

Drug Screening Product
Analytical Instruments
Rapid Testing Devices
Oral Fluid Testing Devices
Consumables
Drug Screening Service

Drug Screening Market, By Sample Type:

Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

Drug Screening Market, By End User:

Drug Testing Laboratories
Workplaces
Criminal Justice and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools and Colleges

Drug Screening Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.

Available Customizations:

Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Screening Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
- 5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
- 5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Drug Screening Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product & Services
- 6.2.2. By Sample Type
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Drug Screening Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product & Services
    - 6.3.1.2.2. By Sample Type
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Drug Screening Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product & Services
    - 6.3.2.2.2. By Sample Type
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Drug Screening Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product & Services
    - 6.3.3.2.2. By Sample Type
    - 6.3.3.2.3. By End User

7. Europe Drug Screening Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product & Services
- 7.2.2. By Sample Type
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Drug Screening Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product & Services
    - 7.3.1.2.2. By Sample Type
    - 7.3.1.2.3. By End User
- 7.3.2. France Drug Screening Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product & Services
    - 7.3.2.2.2. By Sample Type
    - 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Drug Screening Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product & Services
    - 7.3.3.2.2. By Sample Type
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Drug Screening Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product & Services
    - 7.3.4.2.2. By Sample Type
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Drug Screening Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product & Services
    - 7.3.5.2.2. By Sample Type
    - 7.3.5.2.3. By End User

8. Asia Pacific Drug Screening Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product & Services
- 8.2.2. By Sample Type
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Drug Screening Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product & Services
    - 8.3.1.2.2. By Sample Type
    - 8.3.1.2.3. By End User
- 8.3.2. India Drug Screening Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product & Services
    - 8.3.2.2.2. By Sample Type
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Drug Screening Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product & Services
    - 8.3.3.2.2. By Sample Type
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Drug Screening Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product & Services
    - 8.3.4.2.2. By Sample Type
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Drug Screening Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product & Services
    - 8.3.5.2.2. By Sample Type
    - 8.3.5.2.3. By End User

9. Middle East & Africa Drug Screening Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product & Services
- 9.2.2. By Sample Type
- 9.2.3. By End User
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Drug Screening Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product & Services
    - 9.3.1.2.2. By Sample Type
    - 9.3.1.2.3. By End User
- 9.3.2. UAE Drug Screening Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product & Services
    - 9.3.2.2.2. By Sample Type
    - 9.3.2.2.3. By End User
- 9.3.3. South Africa Drug Screening Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product & Services
    - 9.3.3.2.2. By Sample Type
    - 9.3.3.2.3. By End User

10. South America Drug Screening Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product & Services
- 10.2.2. By Sample Type
- 10.2.3. By End User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Drug Screening Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product & Services
    - 10.3.1.2.2. By Sample Type
    - 10.3.1.2.3. By End User
- 10.3.2. Colombia Drug Screening Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product & Services
    - 10.3.2.2.2. By Sample Type
    - 10.3.2.2.3. By End User
- 10.3.3. Argentina Drug Screening Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product & Services
    - 10.3.3.2.2. By Sample Type
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Quest Diagnostics Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Heska Corporation
15.3. Thermo Fisher Scientific, Inc.
15.4. Alfa Scientific Designs, Inc.
15.5. OraSure Technologies, Inc.
15.6. F. Hoffmann-La Roche Ltd
15.7. MPD Inc.
15.8. Shimadzu Corporation
15.9. Lifeloc Technologies, Inc.
15.10. Dragerwerk AG & Co. KGaA
15.11. Premier Biotech, Inc.
15.12. Omega Laboratories, Inc.